JOURNAL OF THORACIC ONCOLOGY, vol 8 Fishbein, MC; Gardner, B; Milne, GL; Koczywas, M; Cristea, M; Dowell, JE; et al.(2013). MODULATION OF THE CYCLOOXYGENASE PATHWAY IS ASSOCIATED WITH EFFICACY IN A RANDOMIZED PHASE II TRIAL OF ERLOTINIB AND CELECOXIB OR PLACEBO IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC). JOURNAL OF THORACIC ONCOLOGY, 8, S1094-S1094. UCLA: Retrieved from: http://www.escholarship.org/uc/item/92j353f1